A Cross Sectional Study of Relationship between Quality Of Life & Medication Compliance in Patients of Diabetes and Hypertension

The study's major goal was to evaluate the relationship between patients' quality of life and medication adherence among primary care patients with diabetes and/or hypertension. A secondary objective was to assess the impact of interaction between disease type and medication adherence on QoL. Throughout the present investigation, a cross-sectional approach was applied. Between January and May of 2023, information was gathered from five distinct primary healthcare facilities in Bangladesh and Pakistan. A study involving 18+ participants with Type 1 or Type 2 diabetes, hypertension, or both for at least six months was conducted in two independent regions. Primary care physicians evaluated medical adherence, quality of life, and general health assessments using self-administered questionnaires and standardized instruments, using SPSS Version 26 for all studies. A study involving over 300 people found that medication adherence was an independent predictor of quality of life (QoL) among patients with diabetes and/or hypertension. The majority were female, unemployed, and obese, with 45.4% on four different drugs and multiple comorbidities. Patients with married and male status had higher overall QoL scores. It is found that by guaranteeing effective patient counseling and streamlining the suggested dose regimen, medication adherence can be increased. In comparison with non-adherent individuals, individuals who adhere probably have greater quality of life and general health. Our research also revealed that smoking habits, gender, and marital status were important determinants of QoL. During routine clinical consultations, healthcare professionals who are providing treatment to patients with diabetes and/or hypertension must encourage medication adherence and involve patients in the decision-making process.